A detailed history of Clear Alpha Technologies LP transactions in Axonics, Inc. stock. As of the latest transaction made, Clear Alpha Technologies LP holds 120,955 shares of AXNX stock, worth $8.59 Million. This represents 2.34% of its overall portfolio holdings.

Number of Shares
120,955
Previous 96,403 25.47%
Holding current value
$8.59 Million
Previous $6.48 Billion 29.89%
% of portfolio
2.34%
Previous 2.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $1.65 Million - $1.71 Million
24,552 Added 25.47%
120,955 $8.42 Billion
Q2 2024

Aug 13, 2024

BUY
$66.47 - $69.65 $1.57 Million - $1.65 Million
23,624 Added 32.46%
96,403 $6.48 Billion
Q1 2024

May 13, 2024

BUY
$56.67 - $69.36 $4.12 Million - $5.05 Million
72,779 New
72,779 $5.02 Billion

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Clear Alpha Technologies LP Portfolio

Follow Clear Alpha Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Alpha Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Clear Alpha Technologies LP with notifications on news.